Coumarin Resistance
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
6
|
10
|
0.800 |
strong |
0.933 |
15 |
8
|
2004 |
2018 |
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
1
|
0.700 |
strong |
1.000 |
3 |
1
|
2004 |
2011 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.370 |
None |
0.857 |
7 |
2
|
2006 |
2019 |
Coronary heart disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1576
|
1178
|
0.340 |
None |
1.000 |
4 |
1
|
2006 |
2013 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.320 |
None |
1.000 |
2 |
|
2006 |
2007 |
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
6
|
4
|
0.310 |
None |
1.000 |
2 |
|
2004 |
2016 |
Acute Cerebrovascular Accidents
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
155
|
2
|
0.310 |
None |
1.000 |
2 |
|
2006 |
2014 |
Blood Coagulation Disorders
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
267
|
31
|
0.310 |
None |
1.000 |
2 |
1
|
2008 |
2008 |
WARFARIN SENSITIVITY (disorder)
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
8
|
0.300 |
None |
1.000 |
17 |
2
|
2004 |
2019 |
Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
47
|
|
0.300 |
None |
1.000 |
2 |
|
2010 |
2015 |
Aortic Aneurysm, Ruptured
|
disease |
Cardiovascular Diseases; Wounds and Injuries
|
Disease or Syndrome
|
13
|
1
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Aortic Rupture
|
disease |
Cardiovascular Diseases; Wounds and Injuries
|
Disease or Syndrome
|
22
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Thrombus
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
46
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Calcification of the aorta
|
phenotype |
|
Pathologic Function
|
21
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Body Fat Distribution
|
phenotype |
|
Finding
|
90
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Reduced prothrombin antigen
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Reduced factor VII activity
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Reduced factor X activity
|
phenotype |
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Bleeding tendency
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
71
|
14
|
0.100 |
None |
|
0 |
|
|
|
Reduced factor IX activity
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of blood and blood-forming tissues
|
disease |
|
Finding
|
23
|
1
|
0.100 |
None |
|
0 |
|
|
|